[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 369
Citations 0
Special Communication
August 2016

Management of Persistent or Recurrent Structural Neck Disease in Differentiated Thyroid CarcinomaPoint and Counterpoint

Author Affiliations
  • 1Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston
  • 2now with Clayman Thyroid Cancer Center, Tampa General Hospital, Wesley Chapel, Florida
  • 3Department of Otolaryngology–Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio
JAMA Otolaryngol Head Neck Surg. 2016;142(8):789-791. doi:10.1001/jamaoto.2016.1114

The optimal management of structurally identified neck disease after initial surgery for thyroid carcinoma is nuanced and must be individually tailored to the patient and his or her disease. As such, it is ideally evaluated and managed with the patient from an experienced interdisciplinary program perspective. Proficiency and focused expertise in diagnostic imaging (ultrasound, cross-sectional, and nuclear), pathology, surgery, endocrinology, radiation oncology, and systemic therapy are integral components of such a program. A thorough understanding of the risks of the disease and treatment options, including management of complications, is required. While no single algorithm is available, several large series, systematic reviews, and guidelines have been published, from which some generalities can be gleaned.18

First Page Preview View Large
First page PDF preview
First page PDF preview